Cycloferon 125 mg/ml soluţie injectabilă Moldova - Kiromania - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

cycloferon 125 mg/ml soluţie injectabilă

polisan srl, ffŞt - methylglucaminum acridonacetatum - soluţie injectabilă - 125 mg/ml

Imudon 2,7 mg comprimate de supt Moldova - Kiromania - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

imudon 2,7 mg comprimate de supt

farmstandart-tomschimfarm sad - combinaţie - comprimate de supt - 2,7 mg

REMUREL 20 mg/ml Romania - Kiromania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

remurel 20 mg/ml

synthon hispania s.l. - spania - glatiramer acetat - sol. inj. in seringa preumpluta - 20mg/ml - cytokine si imunomodulatoare alte cytokine si imunomodulatoare

REMUREL 40 mg/ml Romania - Kiromania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

remurel 40 mg/ml

synthon hispania, s.l. - spania - glatiramer acetat - sol inj. in seringa preumpluta - 40mg/ml - cytokine si imunomodulatoare alte cytokine si imunomodulatoare

LUIVAC 3 mg Romania - Kiromania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

luivac 3 mg

daiichi sankyo europe gmbh - germania - diverse-produse biologic - compr. - 3mg - imunostimulante imunostimulante

Broncho-Munal P 3.5 mg capsule Moldova - Kiromania - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

broncho-munal p 3.5 mg capsule

lek pharmaceuticals d.d. - combinaţie - capsule - 3.5 mg

Broncho-Munal 7 mg capsule Moldova - Kiromania - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

broncho-munal 7 mg capsule

lek pharmaceuticals d.d. - combinaţie - capsule - 7 mg

Urostim 50 mg comprimate Moldova - Kiromania - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

urostim 50 mg comprimate

gm pharmaceuticals ltd. - liofilizat de celule bacteriene - comprimate - 50 mg

Plerixafor Accord Umoja wa Ulaya - Kiromania - EMA (European Medicines Agency)

plerixafor accord

accord healthcare s.l.u. - plerixafor - multiple myeloma; hematopoietic stem cell transplantation - imunostimulante, - adult patientsplerixafor accord is indicated in combination with granulocyte-colony stimulating factor (g-csf) to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in adult patients with lymphoma or multiple myeloma whose cells mobilise poorly (see section 4. paediatric patients (1 to less than 18 years)plerixafor accord is indicated in combination with g-csf to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in children with lymphoma or solid malignant tumours, either:- pre-emptively, when circulating stem cell count on the predicted day of collection after adequate mobilization with g-csf (with or without chemotherapy) is expected to be insufficient with regards to desired hematopoietic stem cells yield, or- who previously failed to collect sufficient haematopoietic stem cells (see section 4.

PLERIXAFOR MSN 20 mg/ml Romania - Kiromania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

plerixafor msn 20 mg/ml

msn labs europe limited - malta - plerixaforum - sol inj. - 20mg/ml - cytokine si imunomodulatoare alte cytokine si imunomodulatoare